Bactrim coverage of strep pyogenes

Bactrim coverage of strep pyogenes

Find patient medical information for Sulfamethoxazole/Trimethoprim (Bactrim, Septra, others) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user. Bactrim (Trimethoprim and Sulfamethoxazole) may treat UTI, side effects, dosage, drug interactions, warnings, patient labeling, and more Bactrim and Bactrim DS are antibiotics used to treat ear infections, urinary tract infections, bronchitis, traveler's diarrhea, shigellosis, and Pneumocystis jiroveci pneumonia. Detailed dosage guidelines and administration information for Bactrim (sulfamethoxazole and trimethoprim). Includes dose adjustments, warnings and precautions. Dans quel cas le médicament BACTRIM est-il prescrit ? Ce médicament est une association de deux antibiotiques : le sulfaméthoxazole, de la famille des sulfamides, et le triméthoprime, de la famille des diaminopyrimidines. Trimethoprim/sulfamethoxazole, sold under the trade names Bactrim, Cotrim (a short form of the British Approved Name, Co-trimoxazole) and Septra, among others, is a fixed-dose combination antibiotic medication used to treat a variety of bacterial infections. [2] Bactrim (sulfamethoxazole / trimethoprim) is a sulfa antibiotic that treats bacterial infections. The most common Bactrim side effects are nausea, diarrhea, and skin changes. Learn about uses, side effects, dosage, and more for Bactrim. It's a prescription oral tablet used to treat certain types of infection in adults and some children. Medscape - Indication-specific dosing for Bactrim, Bactrim DS, Septra, Septra DS, Cotrim, cotrimoxazole, Sulfatrim (trimethoprim, sulfamethoxazole), frequency-based adverse effects. Sulfamethoxazole and trimethoprim combination is used to treat infections including urinary tract infections, middle ear infections (otitis media), bronchitis, traveler's diarrhea, and shigellosis (bacillary dysentery).

Leave a Reply

Your email address will not be published. Required fields are marked *

*
*